Context Therapeutics Inc
NASDAQ:CNTX
Context Therapeutics Inc
NASDAQ:CNTX
Price:
2.6
USD
8.33%
Market Closed
Market Cap:
$238.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Context Therapeutics Inc
NASDAQ:CNTX
|
US |
|
Tennant Co
NYSE:TNC
|
US |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
CH |
|
9
|
908 Devices Inc.
NASDAQ:MASS
|
US |
|
URU Metals Ltd
LSE:URU
|
CA |
|
Hydrogenpro ASA
OSE:HYPRO
|
NO |
|
T
|
TotalEnergies SE
XMUN:TOTB
|
FR |
Wall St Price Targets
CNTX Price Targets Summary
Context Therapeutics Inc
Context Therapeutics Inc
Wall Street analysts forecast CNTX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CNTX is 6.12 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
Lowest Forecast
Price Target
4.04
USD
55% Upside
Average Forecast
Price Target
6.12
USD
135% Upside
Highest Forecast
Price Target
9.45
USD
263% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CNTX's stock price target?
Price Target
6.12
USD
6.12
USD
According to Wall Street analysts, the average 1-year price target for CNTX is 6.12 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
